Close

Guidance for Ani Pharmaceuticals (ANIP)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2024 $4.26 – $4.67 $4.33 $520.00M – 542.00M $506.20M = Maintained Details
2023 $3.62 – $4.11 $3.32 $425.00M – 445.00M $402.90M = Maintained Details
Q2 2023 $2.99 – $3.45 $2.43 $385.00M – 410.00M $371.30M = Maintained Details
2022 $1.34 – $1.62 $1.15 $295.00M – 315.00M $292.80M = Maintained Details
2022 N/A N/A $260.00M – 275.00M $301.60M = Maintained Details
2022 $1.34 – $1.62 $1.37 $295.00M – 315.00M $303.00M = Maintained Details
2022 $1.34 – $1.62 $1.43 $295.00M – 315.00M $305.00M = Maintained Details
2020 $4.46 – $4.86 $5.47 $213.00M – 223.00M $229.15M = Maintained Details
2019 $5.57 – $6.21 $5.79 $231.00M – 245.00M $243.37M = Maintained Details
2019 N/A N/A $231.00M – 245.00M $240.22M = Maintained Details
2019 $5.06 – $5.23 $5.73 $209.00M – 212.00M $222.67M = Maintained Details
2019 $5.57 – $6.21 $6.01 $220.00M – 226.00M $239.80M Lowered Details
2018 $5.43 – $6.08 $4.76 N/A N/A = Maintained Details
2018 $4.80 – $5.27 $5.74 $195.00M – 205.00M N/A Lowered Details
2018 $4.80 – $5.27 $4.91 $195.00M – 205.00M $200.04M = Maintained Details
Q2 2018 N/A N/A N/A N/A = Maintained Details
2017 $3.58 – $3.94 $3.79 $181.00M – 190.00M $182.55M = Maintained Details
2017 $3.58 – $3.94 N/A $181.00M – 190.00M N/A = Maintained Details
Q2 2017 N/A N/A N/A N/A = Maintained Details
2016 $3.54 – $3.91 $3.41 $119.00M – 134.00M $117.87M = Maintained Details
2016 N/A N/A $105.00M – 120.00M $91.80M Raised Details
2016 $4.00 – $4.25 $3.63 $119.00M – 134.00M $124.20M Raised Details
2016 $4.00 – $4.25 $4.09 $128.00M – 134.00M $126.10M = Maintained Details
2015 $2.83 – $2.96 $2.44 $75.50M – 78.30M $82.40M = Maintained Details
2015 $2.48 – $2.72 $2.67 $80.00M – 88.00M $91.60M = Maintained Details
Q4 2015 $0.60 – $0.76 $0.70 $17.20M – 20.00M $22.70M = Maintained Details
Q4 2014 $0.60 – $0.65 $0.45 $17.00M – 18.00M $15.20M = Maintained Details